Sophie Buhelt
Glostrup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: February 25, 2026
Cerebrospinal fluid exosomal Epstein-Barr virus microRNAs in multiple sclerosis and effects of disease modifying therapies.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 25, 2025
A role for DICAM+ mononuclear phagocytes in controlling neuroinflammation in multiple sclerosis.
Journal: Frontiers in immunology
Published: May 14, 2025
Corrigendum to "Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis" [Journal of neuroimmunology vol. 381 (2023): 578128].
Journal: Journal of neuroimmunology
Published: April 11, 2025
Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.
Journal: Journal of neuroimmunology
Published: December 03, 2024
Cerebrospinal fluid soluble CD27 is a sensitive biomarker of inflammation in autoimmune encephalitis.
Journal: Journal of the neurological sciences
Published: October 31, 2023
Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control.
Journal: Frontiers in immunology
Published: June 28, 2023
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis.
Journal: Journal of neuroimmunology
Published: May 03, 2023
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 26, 2022
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 24, 2022
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 03, 2022
IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells.
Journal: Frontiers in immunology
Published: March 04, 2021
Last Updated: 09/26/2026